Illinois Municipal Retirement Fund lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 17.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 101,438 shares of the company's stock after selling 20,914 shares during the quarter. Illinois Municipal Retirement Fund owned approximately 0.08% of Henry Schein worth $6,947,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in the stock. Investment Management Corp VA ADV acquired a new stake in Henry Schein during the fourth quarter worth $32,000. Rakuten Securities Inc. acquired a new stake in Henry Schein in the first quarter worth $34,000. Smartleaf Asset Management LLC grew its position in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the period. UMB Bank n.a. lifted its holdings in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after purchasing an additional 201 shares in the last quarter. Finally, Menard Financial Group LLC acquired a new position in shares of Henry Schein during the 4th quarter worth about $92,000. Institutional investors own 96.62% of the company's stock.
Henry Schein Price Performance
Shares of HSIC traded down $0.03 during midday trading on Wednesday, hitting $74.45. 825,727 shares of the company traded hands, compared to its average volume of 1,716,986. The stock has a market cap of $9.06 billion, a price-to-earnings ratio of 23.27, a PEG ratio of 2.36 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The firm has a 50 day moving average of $70.16 and a 200-day moving average of $71.15. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the company posted $1.10 EPS. Henry Schein's quarterly revenue was down .1% on a year-over-year basis. On average, analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of research analysts have commented on the company. Piper Sandler decreased their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Barrington Research cut their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Wells Fargo & Company dropped their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Finally, Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $79.30.
Get Our Latest Research Report on HSIC
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.